Cernos Depot Injection 4 ml (Testosterone Undecanoate)

Cernos Depot Injection 4 ml (Testosterone Undecanoate)

Cernos Depot is a high-potency endocrine intervention containing Testosterone Undecanoate, a long-acting ester of the primary endogenous androgen. Specifically engineered for the clinical management of primary and secondary hypogonadism in men, this formulation utilizes a unique “Lipophilic-Depot” delivery system. It works by concurrently modulating the organized release of testosterone into the systemic circulation and reinforcing the structural integrity of masculine physiological pathways. By neutralizing the biochemical triggers of androgen deficiency and facilitating the organized stabilization of serum testosterone levels, Cernos Depot effectively promotes an immediate increase in physical vitality and a reduction in metabolic dullness. This targeted biochemical action provides a decisive therapeutic response by reinforcing the structural uniformity of the endocrine system and promoting a stable, physiological recovery from hormonal stressors.

Key Features

• Specifically formulated with Testosterone Undecanoate to ensure a robust defense against fluctuating hormonal levels.
• Clinically recognized for its role in facilitating the natural optimization of bone density, muscle mass, and erythropoiesis.
• Specifically engineered to reach therapeutic levels steadily over an extended period (typically 10 to 14 weeks), ensuring a consistent hormonal profile.
• Acts as a functional catalyst to stabilize mood, cognitive function, and energy levels within the masculine physiological axis.
• Formulated as a high-volume intramuscular injection to address hormonal fatigue through a stabilized, infrequent delivery schedule.

Key Ingredients

• Testosterone Undecanoate (1000 mg/4 ml)
• Benzyl Benzoate
• Refined Castor Oil

Precautions

• This is a high-potency endocrine health intervention. Administration must be performed by a healthcare professional after a formal clinical diagnosis and prostate screening.
• Strictly contraindicated for individuals with suspected or confirmed carcinoma of the prostate or mammary gland.
• Inform your specialist if you have a history of severe hypertension, heart disease, or renal impairment before administration.
• In rare cases, the oil-based solution may cause a temporary pulmonary microembolism (PME); seek immediate assistance if sudden coughing or dizziness occurs post-injection.
• Regular assessment of serum testosterone, hematocrit, and PSA levels is recommended to ensure the physiological safety of the restoration cycle.
• Store the vial in a cool, dry place (below 30°C). Protect from direct light and do not refrigerate to maintain the molecular stability of the oily solution.

How to Use

• The solution must be visually inspected for clarity. The injection should be administered immediately after the vial is opened.
• A single 4 ml (1000 mg) injection constitutes the standard therapeutic dose, typically administered every 10 to 14 weeks as dictated by clinical requirements.
• For optimal clinical results, the second dose is often administered 6 weeks after the first to rapidly establish steady-state concentrations.
• Administer via very slow deep intramuscular injection into the gluteal muscle. Care must be taken to avoid intravascular injection.
• Use as the primary intervention in a long-term hormonal restoration regimen as dictated by your endocrine specialist.
• Maintain the prescribed injection intervals to document visible improvements in systemic vitality and the restoration of hormonal equilibrium over a sustained period.

Legal Disclaimer: Cernos Depot Injection is a specialized pharmacological intervention. Individual results vary based on the patient’s baseline hormonal state and physiological response. This product is for use under professional medical guidance only. This information is for educational purposes and is not a substitute for professional medical consultation or a formal clinical diagnosis.